PVigi

Pharmacovigilance case studies

How PVigi helped pharmaceutical companies, biotechs and CROs with QPPV services, literature monitoring, case processing, risk management, audits and market entry.

Literature monitoring
✓Potential Safety Signals Detected Early

Local Literature Review for Signal Detection

Systematic local and global literature screening that surfaced potential safety signals early.

Read case study →
Regulatory intelligence
25+Countries Monitored Every Month

Regulatory Intelligence Across 25+ Countries

Monthly PV regulatory monitoring for 11 Middle Eastern, 6 North African and 11 European countries.

Read case study →
Risk management
✓RMP Approved, Product Kept on the Market

Risk Management Plan for a High-Risk Marketed Product

A tailored RMP that kept a product under regulatory scrutiny on the market.

Read case study →
QPPV & LCPPV
25+Countries with QPPV / LCPPV

QPPV & LCPPV Services in 25+ Countries

QPPV and local PV contacts appointed in more than 25 countries across Europe, Africa and the Middle East.

Read case study →
Benefit-risk
✓Marketing Authorisation Maintained

Benefit-Risk Assessment for a High-Risk Product

A rigorous benefit-risk assessment that regulators accepted, preserving the marketing authorisation.

Read case study →
Case processing
50%Faster Adverse Event Processing

50% Faster Adverse Event Processing

A compliant safety database and streamlined workflow that cut AE processing time by about half.

Read case study →
Clinical safety
100%SUSARs and DSURs Submitted on Time

SUSAR and DSUR Submissions for a CRO

On-time SUSAR and DSUR submissions across several global clinical trials.

Read case study →
Audit & inspection
0Critical Findings in the PV Audit

PV Audit Passed With No Critical Findings

Pre-audit assessment, remediation and mock audits ahead of a regulatory PV audit.

Read case study →
Regulatory
25+Markets with Approval and PV in Place

Market Entry in the Middle East, North Africa and Europe

Regulatory strategy, PV systems and submissions for 25+ markets.

Read case study →

Talk to a pharmacovigilance expert

Tell us about your products and markets. We reply within one business day with a clear proposal.

Get a proposal